InfYnity Biomarkers
keyboard_backspaceBack to Home
Contact
78-80 rue du Bourbonnais
69009 Lyon
France
Responsable Marketing et Ventes
About us
Founded in 2009 in Lyon, InfYnity Biomarkers is a biotechnology R&D company specialized in immunology and infectiology within the in vitro diagnostics (IVD) sector. The company’s objective is to develop innovative immunoassay solutions for infectious diseases which will significantly improve disease diagnosis and prognosis as well as monitor drug/vaccine efficacy.
InfYnity Biomarkers has been collaborating with academic institutions, healthcare organizations and leading industrial partners for over 15 years.
Business offer
InfYnity Biomarkers has a high specialization in the cutting-edge multiplex technology for serology-based applications in infectiology. The company’s core expertise are Multiplex technology, Biomaterial design and Immunoassay development.
1- Multiplex Technology
InfYnity Biomarkers has acquired a high-end specialization in the multiplex technology and the development of multiplex ELISA immunoassays. These immunoassays allow simultaneous detection of antibodies against a set of selective and validated antigens of a blood sample. These tests are very innovative because they allow to read serological signatures in patients and can therefore provide highly relevant clinical information.
2- Critical Raw Materials
InfYnity Biomarkers has a strong expertise in the design of recombinant proteins and antibodies using epitope mapping. The company offers a broad range of high performing antigens and antibodies for different infectious agents such as : HIV, HCV, HTLV, Syphilis, Chagas, Onchocerciasis etc.
3- Customized Development Services
InfYnity Biomarkers provides customized immunobiology projects and services, covering everything from biomaterial design to biomarker discovery and immunoassay development. The company provides fine-tuned solutions in order to meet the specific requirements of clients.
Activities
- Therapeutic Product
- Research Unit
- Infectiology
- Immunology
- Inflammation
- Target selection & validation
- Gene / protein discovery
- Hit discovery
- Screening & Identification
- Therapeutic libraries
- In-vivo models
- Preclinical biomarkers
- Mechanism/Function
- Level of response duration
- Predictive biomarkers
- Treatment efficacy
- Disease progression / follow-up
- Clinical biomarkers
- Predictive biomarkers
- Disease progression / follow-up
- Disease progression monitoring
- Companion biomarkers
- Treatment monitoring
